Novavax, Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript November 6, 2025
Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 EPS, expectations were $-1.08.
Operator: Good morning, and welcome to Novavax’s Third Quarter 2025 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded, and I would now like to turn the conference over to Luis Sanay, Vice President-Investor Relations. Please go ahead,...
